Vinorelbine Related Clinical Trials
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer [Completed]
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer [Completed]
Vinorelbine/Gemcitabine Verses Vinorelbine/Carboplatin in Advanced Non-Small Cell Lung Cancer [Recruiting]
BIBW 2992 and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 [Recruiting]
Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects [Recruiting]
Metronomic Oral Vinorelbine in Patients With Metastatic Tumors [Completed]
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-Line Treatment of Advanced Non Small Cell Lung Cancer(FLEX) [Completed]
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma [Completed]
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer [Recruiting]
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [Recruiting]
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Recruiting]
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer [Recruiting]
Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab [Recruiting]
A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer [Completed]
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer [Recruiting]
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases [Recruiting]
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours [Recruiting]
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer [Recruiting]
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer [Recruiting]
Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer [Recruiting]
A Phase II Study of Gemcitabine in Combination With Vinorelbine vs. Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer [Completed]
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer [Recruiting]
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Completed]
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer [Recruiting]
Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas [Recruiting]
Phase II Iressa Versus Vinorelbine (INVITE) [Completed]
Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer [Recruiting]
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer [Recruiting]
Navelbine And Radiotherapy in Locally Advanced Lung Cancer [Recruiting]
Lapatinib in Combination With Vinorelbine [Recruiting]
Lapatinib in Combination With Vinorelbine [Recruiting]
Vinorelbine and XR9576 to Treat Cancer [Completed]
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas [Completed]
Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) [Recruiting]
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse [Recruiting]
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer [Recruiting]
An Open-Label Phase I Study of Weekly ABI-007 and Vinorelbine With or Without G-CSF in Patients With Stage IV (Metastatic) Breast Cancer [Active, not recruiting]
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer [Recruiting]
Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC. [Completed]
Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer [Completed]
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [Active, not recruiting]
Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Completed]
Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Recruiting]
Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients [Completed]
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer [Active, not recruiting]
Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer [Active, not recruiting]
Preoperative Herceptin and Navelbine for Breast Cancer [Active, not recruiting]
Vinorelbine in Treating Patients With Stage IV Melanoma [Active, not recruiting]
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. [Completed]
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer [Active, not recruiting]
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors [Active, not recruiting]
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma [Active, not recruiting]
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer [Active, not recruiting]
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Recruiting]
Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [No longer recruiting]
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]
Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Suspended]
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer [Active, not recruiting]
Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer [Completed]
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) [Terminated]
Vinorelbine in Treating Patients With Metastatic Prostate Cancer [No longer recruiting]
HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer [No longer recruiting]
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Recruiting]
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy [No longer recruiting]
Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer [No longer recruiting]
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis [No longer recruiting]
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer [No longer recruiting]
Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies [Recruiting]
Vinorelbine in Treating Older Women With Stage IV Breast Cancer [No longer recruiting]
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases [No longer recruiting]
Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer [No longer recruiting]
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer [No longer recruiting]
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients [No longer recruiting]
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer [No longer recruiting]
Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With NSCLC [Recruiting]
Randomized Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With NSCLC [Recruiting]
Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer [Completed]
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [No longer recruiting]
Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed [No longer recruiting]
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer [Recruiting]
Docetaxel and Vinorelbine Plus Sargramostim in Malignant Melanoma [Recruiting]
Study With Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer [Recruiting]
Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement [No longer recruiting]
Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery [No longer recruiting]
Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) [Recruiting]
Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Recruiting]
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction [Recruiting]
Effects of Granulocyte Colony-Stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Recruiting]
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial [Active, not recruiting]
Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm [Recruiting]
Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer [Recruiting]
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer [Recruiting]
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors [Recruiting]
Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [No longer recruiting]
|
